Dopamine transporter development in postnatal rat striatum, an autoradiographic study with [3H]WIN 35,428

被引:28
|
作者
Coulter, CL
Happe, HK
Murrin, LC
机构
[1] Univ Nebraska, Med Ctr, Dept Pharmacol, Omaha, NE 68198 USA
[2] Creighton Univ, Sch Med, Dept Neurol, Omaha, NE 68131 USA
[3] Univ Nebraska, Med Ctr, Dept Internal Med, Neurol Sect, Omaha, NE 68198 USA
来源
DEVELOPMENTAL BRAIN RESEARCH | 1997年 / 104卷 / 1-2期
关键词
dopamine transporter; development; WIN 35,248; cocaine receptor; caudate-putamen; autoradiography;
D O I
10.1016/S0165-3806(97)00135-1
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The dopamine transporter mediates the reinforcing effects of cocaine, thus playing a central role in human cocaine addiction, and perhaps providing the mechanism for inducing the effects of prenatal cocaine exposure. This possibility has stimulated growing interest in the normal and abnormal development of this transporter. [H-3]WIN 35,428 is a cocaine analog that is useful for studying the distribution and density of the dopamine transporter in striatum and other brain regions. The postnatal development of the dopamine transporter in the rat striatum was measured by quantitative autoradiography with [H-3]WIN 35,428. Dopamine transporter levels were low at birth, increased through day 15, followed by much more rapid growth in late postnatal development. The majority of the transporter sites appeared after day 15. Lateral to medial and anterior to posterior gradients in transporter density were established early during development, and there was also an early concentration of transporter in striosomes that became difficult to identify by day 15. Differences between the developmental patterns described here and studies using other ligands for the dopamine transporter suggest there are significant differences in the transporter binding sites for these drugs. These differences in transporter ligand binding characteristics may reflect developmental changes in post-translational modification of the transporter and/or changes in the functional activity rather than simply the presence of the transporter. (C) 1997 Elsevier Science B.V.
引用
收藏
页码:55 / 62
页数:8
相关论文
共 50 条
  • [31] INVIVO DOPAMINE TRANSPORTER SITES IMAGING IN HUMAN USING [C-11] WIN 35,428 POSITRON EMISSION TOMOGRAPHY (PET)
    YUNG, BCK
    DANNALS, RF
    KUHAR, MJ
    SHAYA, EK
    RAVERT, HT
    CHEN, C
    CHAN, B
    SCHEFFEL, U
    RICAURTE, G
    FOLIO, T
    WAGNER, HN
    NEUMEYER, M
    WONG, DF
    JOURNAL OF NUCLEAR MEDICINE, 1993, 34 (05) : P197 - P197
  • [32] INVIVO LABELING OF COCAINE BINDING-SITES ON DOPAMINE TRANSPORTERS WITH [H-3] WIN-35,428
    SCHEFFEL, U
    POGUN, S
    STATHIS, M
    BOJA, JW
    KUHAR, MJ
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1991, 257 (03): : 954 - 958
  • [33] 3-aryl-2-carbomethoxybicyclo[3,2,1]oct-2-enes inhibit WIN 35,428 binding potently and selectively at the dopamine transporter
    Meltzer, PC
    Blundell, P
    Huang, H
    Liu, SH
    Yong, YF
    Madras, BK
    BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (03) : 581 - 590
  • [34] Effect of chronic L-DOPA and reserpine treatment on the in vivo binding of H-3 WIN 35,428 to central dopamine transporters.
    Kim, SE
    Hwang, SH
    Oh, SJ
    Choe, YS
    Choi, Y
    Kim, BT
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 1203 - 1203
  • [35] Effect of mazindol on dopamine transporter in normal human brain: Graphic kinetic modeling for [C11]WIN 35,428 with no blood input.
    Yokoi, F
    Dogan, AS
    Stephane, M
    Chen, A
    Wong, DF
    JOURNAL OF NUCLEAR MEDICINE, 1998, 39 (05) : 166P - 167P
  • [36] POSITRON EMISSION TOMOGRAPHIC IMAGING OF THE DOPAMINE TRANSPORTER WITH C-11 WIN 35,428 REVEALS MARKED DECLINES IN MILD PARKINSONS-DISEASE
    FROST, JJ
    ROSIER, AJ
    REICH, SG
    SMITH, JS
    EHLERS, MD
    SNYDER, SH
    RAVERT, HT
    DANNALS, RF
    ANNALS OF NEUROLOGY, 1993, 34 (03) : 423 - 431
  • [37] COCAINE DISPLACES [H-3] WIN 35,428 BINDING TO DOPAMINE UPTAKE SITES INVIVO MORE RAPIDLY THAN MAZINDOL OR GBR-12909
    POGUN, S
    SCHEFFEL, U
    KUHAR, MJ
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 198 (2-3) : 203 - 205
  • [38] Assessing the striatal dopamine system with [F-18] FDOPA and [C-11] WIN 35,428: Terminal synthesis capacity versus transporter density
    Melega, WP
    Raleigh, MJ
    Lacan, G
    Datt, A
    Harvey, DC
    Huang, SC
    Phelps, ME
    JOURNAL OF NUCLEAR MEDICINE, 1997, 38 (05) : 36 - 36
  • [39] Postnatal development of the dopamine transporter: A quantitative autoradiographic study (vol 92, pg 172, 1996)
    Coulter, CL
    Happe, HK
    Murrin, LC
    DEVELOPMENTAL BRAIN RESEARCH, 1997, 98 (01): : 150 - 150
  • [40] Nicotinic modulation of [3H]dopamine release in rat striatum:: Involvement of PKC subtypes.
    Soliakov, L
    Wonnacott, S
    JOURNAL OF NEUROCHEMISTRY, 1998, 71 : S52 - S52